During a recent Congressional hearing, health system CEOs faced little accountability as committee members pointed fingers at opposing party policies for rising health care costs.
The Supreme Court is examining the authority regarding whether pesticide labels should include cancer warnings, focusing on Monsanto's Roundup products containing glyphosate.
This editorial provides a timeline of significant events related to the Trump administration's operations targeting suspected drug traffickers in the Caribbean and Eastern Pacific.
Recent research underscores the importance of zinc in maintaining cellular health, highlighting its dual role in protein quality control and the consequences of its imbalance.
STAT is seeking input on whether to adopt 'healthcare' or 'health care' in its publications. Your opinion matters.
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
Stellantis workers report various health issues, including migraines and nose bleeds, following their return to the office for a five-day work week.
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
Mali is witnessing a significant escalation in violence, marked by the largest coordinated attack in over a decade, involving al-Qaeda-linked jihadists and Tuareg separatists.
Experts argue that neglecting mental illness in conversations about brain health limits our understanding and potential for improvement in this critical area.
The capture of Flores Silva, a prominent associate of the late drug lord 'El Mencho', marks a notable step in Mexico's fight against organized crime.
A clinical trial is set to begin testing an innovative ultrasound treatment for endometriosis nodules in the rectum, potentially offering new hope to affected patients.
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.
Erasca has reported that its experimental treatment for pancreatic and lung cancers has delivered results that exceed initial expectations in early trials.
Robert F. Kennedy Jr. has reportedly failed to provide answers to Democrats' inquiries, particularly regarding a controversial contract, leading to increased frustrations.
The Trump administration has expressed concerns regarding the use of federal funds for fentanyl test strips, indicating a shift away from harm reduction strategies.
Recent research highlights the importance of a five-gene protein in aiding plant growth during the critical seedling phase, potentially influencing agricultural practices.
Archelle Georgiou, a former insider at a major health insurer, discusses the objectives behind prior authorization processes in healthcare.
Astellas is moving forward with its XLMTM gene therapy trials despite earlier reports of deaths. Meanwhile, Veradermics celebrates success in its hair loss pill trial, and the FDA accelerates reviews for psychedelics.
Mali has entered a period of national mourning following the death of its defence minister in an attack attributed to the Al-Qaeda affiliated group JNIM, which has formed an alliance with Tuareg rebels.